BioCryst Pharmaceuticals (MEX:BCRX) Other Current Payables: MXN0 Mil (As of Mar. 2026)


MEX:BCRX BioCryst Pharmaceuticals Inc MEX:BCRX
55 GF Score
Price MXN193.60
GF Value MXN220.05
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is BioCryst Pharmaceuticals Other Current Payables?

BioCryst Pharmaceuticals MEX:BCRX +8.46% 55 Other Current Payables is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:BCRX with a GF Score™ of 55/100 and a GF Value™ of MXN220.05 (Modestly Undervalued). The stock has 4 warning signs investors should review.

BioCryst Pharmaceuticals's Other Current Payables for the quarter that ended in Mar. 2026 was MXN0 Mil.

BioCryst Pharmaceuticals's quarterly Other Current Payables increased from Sep. 2025 (MXN0 Mil) to Dec. 2025 (MXN161 Mil) but then declined from Dec. 2025 (MXN161 Mil) to Mar. 2026 (MXN0 Mil).

BioCryst Pharmaceuticals's annual Other Current Payables declined from Dec. 2023 (MXN314 Mil) to Dec. 2024 (MXN304 Mil) and declined from Dec. 2024 (MXN304 Mil) to Dec. 2025 (MXN161 Mil).

BioCryst Pharmaceuticals Other Current Payables Related Terms

BioCryst Pharmaceuticals Other Current Payables Historical Data

* Premium members only.

The historical data trend for BioCryst Pharmaceuticals's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCryst Pharmaceuticals Other Current Payables Chart

BioCryst Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.80 150.12 314.43 304.28 161.33

BioCryst Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 161.33 0.00
MEX:BCRX
55GF Score
BioCryst Pharmaceuticals Inc MEX:BCRX
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioCryst Pharmaceuticals Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of MXN0 Mil mean?
BioCryst Pharmaceuticals (MEX:BCRX) has a Other Current Payables of MXN0 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on BioCryst Pharmaceuticals and its competitors.
Is BioCryst Pharmaceuticals' Other Current Payables too high?
BioCryst Pharmaceuticals' current Other Current Payables is MXN0 Mil. Overall, BioCryst Pharmaceuticals has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioCryst Pharmaceuticals' Other Current Payables compare to SUPN and PBH?
BioCryst Pharmaceuticals' Other Current Payables of MXN0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on BioCryst Pharmaceuticals and its competitors. BioCryst Pharmaceuticals's current Other Current Payables is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioCryst Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, BioCryst Pharmaceuticals (MEX:BCRX) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN220.05, compared to a current price of MXN193.60 — trading 12% below its estimated fair value. The current Other Current Payables is MXN0 Mil. BioCryst Pharmaceuticals' overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For BioCryst Pharmaceuticals (MEX:BCRX), the current Other Current Payables is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioCryst Pharmaceuticals (MEX:BCRX) Overvalued in 2026?

Based on GuruFocus' analysis, BioCryst Pharmaceuticals stock appears to be undervalued. The current stock price of MXN193.60 is trading 12% below its estimated GF Value™ of MXN220.05. GuruFocus considers BioCryst Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for MEX:BCRX:

  • Other Current Payables: MXN0 Mil
  • GF Value™: MXN220.05 vs. price of MXN193.60 (12% below fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the MEX:BCRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioCryst Pharmaceuticals Business Description

Other Exchanges BCRX:USABO1:Germany
Address 4505 Emperor Boulevard, Suite 200, Durham, NC, USA, 27703
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
55GF Score

Get the complete analysis for MEX:BCRX

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN193.60
Price
MXN220.05
GF Value